Plasma N-Cleaved Galectin-9 Is a Surrogate Marker for Determining the Severity of COVID-19 and Monitoring the Therapeutic Effects of Tocilizumab

Galectin-9 (Gal-9) is known to contribute to antiviral responses in coronavirus disease 2019 (COVID-19). Increased circulating Gal-9 in COVID-19 is associated with COVID-19 severity. In a while, the linker-peptide of Gal-9 is susceptible to proteolysis that can cause the change or loss of Gal-9 acti...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwasaki-Hozumi, Hiroko, Maeda, Yosuke, Niki, Toshiro, Chagan-Yasutan, Haorile, Bai, Gaowa, Matsuba, Takashi, Furushima, Daisuke, Ashino, Yugo, Hattori, Toshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964849/
https://www.ncbi.nlm.nih.gov/pubmed/36835000
http://dx.doi.org/10.3390/ijms24043591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964849/
https://www.ncbi.nlm.nih.gov/pubmed/36835000
http://dx.doi.org/10.3390/ijms24043591

Ejemplares similares